Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Oncology|November 7, 2012
Mammalian target of rapamycin as a rational therapeutic target for breast cancer treatmentPatricia Mucci LoRussoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Inhibition of the PI3K/AKT/mTOR Pathway in Solid TumorsPatricia Mucci LoRussoCurrent Oncology Reports|January 31, 2004
Vascular targeting agentsMary Jo Pilat, Julie McCormick, Patricia Mucci LoRussoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trialRoy S Herbst, Anne-Marie Maddox, Mace L Rothenberg, et al.Chest|June 20, 2020
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical OutcomesChristina C Price, Frederick L Altice, Yu Shyr, et al.Pageof 1